SIPAI HEALTH (00314) bought back 200,000 shares for HK$267,100 on May 13th.
Sino Health (00314) announced on May 13, 2026 that the company would spend 267,100 Hong Kong dollars to repurchase 200,000 shares at a repurchase price of 1.32-1.39 Hong Kong dollars per share.
SIPAI HEALTH (00314) announced on May 13, 2026 that the company will spend 267,100 Hong Kong dollars to repurchase 200,000 shares at a repurchase price of 1.32-1.39 Hong Kong dollars per share.
Related Articles
CONANT OPTICAL (02276) spent 4.4109 million Hong Kong dollars to repurchase 100,000 shares on May 13th.
ZHOU LIU FU (06168): Controlling shareholder voluntarily extends lock-up period commitment.
Huaneng Power (00902) has submitted an application for the issuance of Huaneng Coal Power REIT and the application materials have been accepted for review.
CONANT OPTICAL (02276) spent 4.4109 million Hong Kong dollars to repurchase 100,000 shares on May 13th.
ZHOU LIU FU (06168): Controlling shareholder voluntarily extends lock-up period commitment.
Huaneng Power (00902) has submitted an application for the issuance of Huaneng Coal Power REIT and the application materials have been accepted for review.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
